Tech World Israel
SEE OTHER BRANDS

Hottest science and technology news from Israel

Tech World Israel: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech World Israel.

Press releases published on April 17, 2025

Fordefi & Station70 Launch Industry’s First Failover Wallet Solution for Disaster Recovery

Fordefi & Station70 Launch Industry’s First Failover Wallet Solution for Disaster Recovery

Station70’s SWAT and Fordefi’s Standby Wallet solution offer institutions a unique approach for wallet diversification and enhanced risk mitigation. NEW YORK, NY, UNITED STATES, April 17, 2025 /⁨EINPresswire.com⁩/ -- Fordefi, a leading blockchain …

Serial Entrepreneur Nili Goldberg Launches Transformative Business Book: Your Core-4

Serial Entrepreneur Nili Goldberg Launches Transformative Business Book: Your Core-4

A framework for founders and leaders to align, decide, and scale—faster. MIAMI, FL, UNITED STATES, April 17, 2025 /⁨EINPresswire.com⁩/ -- Entrepreneur, educator, and marketing innovator Nili Goldberg announces the official launch of her powerful new …

Eric Malley Reveals the Untold Story of AI in the Lab vs How Anthropic and Cohere Are Rethinking Innovation

Eric Malley Reveals the Untold Story of AI in the Lab vs How Anthropic and Cohere Are Rethinking Innovation

Exploring how two lesser-known AI companies, Anthropic and Cohere, are driving innovation behind the scenes while branding dominates public perception. NEW YORK, NY, UNITED STATES, April 17, 2025 /⁨EINPresswire.com⁩/ -- In his newest article titled: The …

Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite’s Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients

Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite’s Namodenoson, Leading U.S. Medical Centers Seek Authorization for their Patients

Ramat Gan, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service